Keyphrases
Acute Myeloid Leukemia
100%
Acute Myeloid Leukemia Cells
10%
Adverse Prognostic Factor
100%
Altered Expression
10%
Apoptosis
10%
Botulinum Neurotoxin (BoNT)
10%
Caspase-9
10%
Catenin
10%
CD34+ Cells
10%
Cell Adhesion
10%
Cell Motility
10%
Complete Remission
10%
EGLN1
10%
Event-free Survival
10%
Fibronectin
10%
FMS-like Tyrosine Kinase 3 (FLT3)
20%
Glucose-regulated Protein
10%
Hypoxia
10%
Hypoxia-inducible factor-1α (HIF-1α)
20%
Independent Prognostic Factor
10%
Integrin
10%
Intermediate Cytogenetic Risk
10%
Karyotypic Abnormalities
10%
Large B-cell Lymphoma
10%
Leukemia
20%
Leukemia Stem Cells
10%
Leukemogenesis
10%
Mutational Status
10%
Newly Diagnosed
10%
Non-associated
10%
Nucleophosmin 1 (NPM1)
30%
Overall Survival Rate
10%
Protein Expression
20%
Protein Level
10%
Protein Sample
10%
RAS mutational Status
10%
Rat Sarcoma
10%
Reverse Phase Protein Array
10%
Stem Cell Homeostasis
10%
TRIM62
100%
Tripartite Motif
10%
Tumor Suppressor
10%
Tumor Suppressor Gene
10%
Viral Oncogenes
10%
Biochemistry, Genetics and Molecular Biology
B Cell
16%
Botulinum Toxin
16%
Caspase-9
16%
Catenin
16%
CD34
16%
Cell Adhesion
16%
Cell Motility
16%
Cytogenetics
16%
Event Free Survival
16%
Fibronectin
16%
Glucose-Regulated Protein
16%
Homeostasis
16%
Hypoxia Inducible Factor 1
33%
Integrin
16%
Myeloid
100%
Notch
16%
NPM1
33%
Overall Survival
16%
Protein Expression
16%
Protein Microarray
16%
Receptor Tyrosine Kinase
33%
Stem Cell
16%
Survival Rate
16%
Tumor Suppressor Gene
16%
Tumor Suppressor Protein
16%
Tyrosine Kinase
33%
Virus Oncogene
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
B Cell Lymphoma
16%
Caspase 9
16%
Catenin
16%
CD135 Antigen
33%
Event Free Survival
16%
Exoenzyme C3
16%
Fibronectin
16%
Glucose Regulated Protein
16%
Hypoxia
16%
Hypoxia Inducible Factor 1
33%
Integrin
16%
Leukemia
50%
Leukemogenesis
16%
Nucleophosmin
16%
Overall Survival
16%
Remission
16%
Sarcoma
16%
Survival Rate
16%
Tumor Suppressor Protein
33%